EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method

Mukaa M Januaris, Wachuka Gathigia Njoroge, Antony Omondi Radol, Jeremiah Gathirwa Waweru

The Journal of Medical Research · 2023

DOI: 10.31254/jmr.2023.9102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Medical Research, 2023. Verfasst von Mukaa M Januaris und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is a type of malignancy that is defined by abnormal development of cells in the prostate tissue. Prostate cancer needs early intervention since its incidence and prevalence is high across the world leading to high morbidity and mortality. Prostatic specific antigen test which is the commonly used screening test in Kenya and across the world is nonspecific, expensive and inaccessible to many people in rural setting who are in need. The definitive histological test is invasive and requires specialized facilities and personnel. This study sought to investigate sarcosine in urine as a predictor of prostate cancer to supplement prostatic specific antigen test in the diagnosis of prostate carcinoma. Cross sectional study design was employed in this study for all suspected prostate cancer identified according to clinical assessment during the study period. Midstream urine samples of about 30mls was collected in plastic tubes, centrifuged and supernatant collected and analyzed using ELISA method for sarcosine. Raw data obtained was tabulated in excel and transferred to statistical package for social science. Differences in means and standard deviation from various age groups was analyzed using one-way Anova and Independent t test. The Bonferroni was used as post Hoc to test the means that were significant from others. Significance level was set at 95%. The concentration of sarcosine (4.30±0.11nmol/ml) in prostate cancer participants was significantly higher than the concentration (0.47±0.06nmol/ml) of control participants using ELISA (p

Zitieren

APA

Januaris, M. M., Njoroge, W. G., Radol, A. O., & Waweru, J. G. (2023). Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method. The Journal of Medical Research. https://doi.org/10.31254/jmr.2023.9102

Vancouver

Januaris MM, Njoroge WG, Radol AO, Waweru JG. Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method. The Journal of Medical Research. 2023. doi:10.31254/jmr.2023.9102

BibTeX
@article{Januaris2023,
  author = {Januaris, Mukaa M and Njoroge, Wachuka Gathigia and Radol, Antony Omondi and Waweru, Jeremiah Gathirwa},
  title = {Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method},
  journal = {The Journal of Medical Research},
  year = {2023},
  doi = {10.31254/jmr.2023.9102}
}
Kostenlos starten →